
CatSci launches API risk assessment tool
Life sciences partner CatSci has launched a digital tool to assess the risk of a company’s active pharmaceutical ingredient (API). SmartPath is a digital tool created by CatSci to assess its customers’ API, project, and formulation data and offer them smart mitigation strategies. Companies using the platform will… Read More


